32-country study shows that type 2 diabetes drug is clinically effective for long-term use
An extended trial of a drug for people with type 2 diabetes has confirmed that the oral DPP-4 inhibitor linagliptin is a safe and effective means of lowering glucose levels for up to 102 weeks, either on its own or in combination ...
Jul 23, 2012
0
0